Related Experiment Video
Updated: Jul 13, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Functionality of the immune system in patients with chronic hepatitis C: trial by superinfections and vaccinations
1Swedish Institute for Infectious Disease Control, Department of Virology, Stockholm, SE 17182, Sweden; and, Ivanovsky Institute of Virology, Moscow, 123098, Russia. maria.isaguliants@smi.ki.se
Insights
Chronic hepatitis C (CHC) impairs the immune system, increasing risks for new viral infections and reducing vaccine effectiveness. Patients need tailored protection against common diseases due to compromised immunity.
Area of Science:
- Immunology
- Hepatology
- Infectious Diseases
Background:
- Chronic viral infections significantly alter host immune responses to subsequent infections and vaccinations.
- The impact of chronic hepatitis C (CHC) on immune status and functionality requires thorough investigation.
Purpose of the Study:
- To evaluate how chronic hepatitis C infection affects a host's immune system.
- To determine the implications for immune memory and the development of new immunity in CHC patients.
- To assess the need for enhanced protective strategies against various infectious agents and vaccines.
Main Methods:
- Review of existing data on immune status in chronically HCV-infected individuals.
- Analysis of immune responses to vaccinations in patients with CHC.
- Evaluation of the literature concerning viral superinfections in the context of CHC.
Main Results:
- Chronic hepatitis C may compromise the host, increasing the risk and altering the course of viral superinfections.
- CHC patients retain immunological memory but exhibit impaired de novo immunity, evidenced by poor responses to hepatitis A and B vaccines.
- Immunity to other diseases like influenza, varicella, tetanus, and diphtheria may also be affected.
Conclusions:
- CHC patients require additional protection against blood-borne and other infectious diseases due to selective immune impairments.
- Vaccination strategies must be adapted to the specific immune deficits observed in CHC.
- Further research is crucial for developing effective immunoprotective approaches for non-responding CHC patients.
Abstract:
Viral infections, specifically chronic, markedly influence the host response to subsequent infections and vaccinations. Does this apply to chronic hepatitis C (CHC)? The review considers this question with implications for the immune status and functionality of the immune system of a chronically HCV-infected host. The data collected here indicate that CHC may increase the risk of viral superinfections and modify their course by immunocompromising the host. Patients with CHC do not lose the 'memory' of previous infections and vaccinations but, apparently, have problems with building such immunity anew, as illustrated by their impaired response to hepatitis A and B vaccinations. This underlines the necessity of extra protection of CHC patients against blood-borne diseases, hepatitis A, possibly also varicella, influenza, tetanus, and diphtheria - immunity to which, in the Western population, appears to falter. Such immune protection has to be adapted to selective impairments of immune response characteristic to CHC. Some approaches to this are reviewed here and more need to be elaborated. Special attention has to be given to CHC patients who do not respond to common vaccines; further studies in this field are of great interest.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Vaccinations
Cell-mediated Immune Responses
Hepatitis
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibitors of Viral Protein Synthesis
